Published in Shanghai Arch Psychiatry on February 01, 2013
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry (2008) 9.54
Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry (2012) 5.45
Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry (2005) 5.17
Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry (2004) 4.74
Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry (2002) 4.60
Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry (2006) 4.18
Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry (2002) 4.06
Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry (2010) 3.82
Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull (2007) 3.15
Symptom assessment in schizophrenic prodromal states. Psychiatr Q (1999) 3.09
Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull (2005) 2.50
The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology (2005) 2.37
Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull (2006) 1.73
Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review. Curr Pharm Des (2012) 1.71
Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort. Early Interv Psychiatry (2010) 1.71
Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry (2009) 1.56
Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatry (2003) 1.49
Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophr Res (2010) 1.37
Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J Child Psychol Psychiatry (2010) 1.36
Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophr Res (2007) 1.23
Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology (2006) 1.20
The promise of early intervention. Early Interv Psychiatry (2007) 1.17
Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation. Biol Psychiatry (2010) 1.05
Randomized controlled multicentre trial of cognitive behaviour therapy in the early initial prodromal state: effects on social adjustment post treatment. Early Interv Psychiatry (2007) 1.00
Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial. J Clin Psychiatry (2007) 0.98
A randomized trial of family focused treatment for adolescents and young adults at risk for psychosis: study rationale, design and methods. Early Interv Psychiatry (2011) 0.95
Neuroprotective agents in schizophrenia and affective disorders. Expert Opin Pharmacother (2006) 0.93
Can antidepressants prevent psychosis? Lancet (2007) 0.93
Real-world implementation of early intervention in psychosis: resources, funding models and evidence-based practice. World Psychiatry (2008) 0.78
Psychosis risk syndrome is not prodromal psychosis. Shanghai Arch Psychiatry (2015) 0.79
Should repetitive Transcranial Magnetic Stimulation (rTMS) be considered an effective adjunctive treatment for auditory hallucinations in patients with schizophrenia? Shanghai Arch Psychiatry (2013) 0.78
Case-control study of error-related negativity among males with heroin dependence undergoing rehabilitation. Shanghai Arch Psychiatry (2013) 0.75
Binocular rivalry in children with schizophrenia: the conscious and unconscious cognitive processing of interpersonal information. Shanghai Arch Psychiatry (2013) 0.75
Is the DSM-5 hoarding disorder diagnosis valid in China? Shanghai Arch Psychiatry (2016) 0.75
Cross-sectional study of the association of cognitive function and hippocampal volume among healthy elderly adults. Shanghai Arch Psychiatry (2014) 0.75
Research in China on the molecular genetics of schizophrenia. Shanghai Arch Psychiatry (2012) 0.75
Research in China on event-related potentials in patients with schizophrenia. Shanghai Arch Psychiatry (2012) 0.75